Join the club for FREE to access the whole archive and other member benefits.

Petr Sramek

Managing Partner at VC LongevityTech.fund, CEO HealthyLongevity.clinic, Biotech board member

Petr Sramek is a Czech visionary, a serial entrepreneur of over 30 years. Petr helps innovative startups in the field of Artificial Intelligence and Longevity technology to grow into confident companies with global ambitions. Petr is a founder of LongevityTech.fund, Entrepreneur in Residence at Singularity University, CEO of Whytics, co-founder of the Platform on Artificial Intelligence at the Confederation of Industry, member of Peter Diamandis´s organization Abundance 360, Lifeboat Foundation, and a Senator for Czech Republic in the World Business Angels Investment Forum (WBAF). Petr is a founder of the AI Awards project in a co-operation with Economia – a leading business media publishing house. Petr has been featured in the group of 28 AI leaders in the flagship World Intellectual Property Organization study.

Visit website: https://www.crunchbase.com/person/petr-sramek

 petrsramek

 PetrSramekBench

See also: Company Longevity Tech Fund - Investing globally in technologies extending healthy lifespans

Details last updated 04-Nov-2022

Petr Sramek is also referenced in the following:

Conference on Healthy Longevity

10-Oct-2023

Live and online event about healthy longevity organised by Slovenian Society for Vital Life Extension (FREE)

Eurosymposium on Healthy Ageing 2022

25-Nov-2022 to 26-Nov-2022

Unique biennial online meeting of scientists working on the biology of ageing organized by Heales and International Longevity Alliance (FREE)

Longevity Med Summit (LMS) 2024

08-May-2024 to 09-May-2024

Leading summit for the Longevity medical industry (Lisboa, Portugal)

Rejuvenation Startup Summit 2024

10-May-2024 to 11-May-2024

The leading networking event for rejuvenation startups, longevity investors and translational researchers by Forever Healthy Foundation

Petr Sramek News

Yuvan's E5 therapy receives investment to move into canine trials

Yuvan's E5 therapy receives investment to move into canine trials

Longevity Technology - 31-Aug-2023

Pig plasma therapy could reverse aging in humans